Tissue Regenix Group plc (TRX.L)
GBp 33.2
(-2.35%)
GBp 33.2
(-2.35%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 11.61 Million GBP | 8.0% |
| 2022 | 10.75 Million USD | 24.81% |
| 2021 | 8.61 Million USD | -6.88% |
| 2020 | 9.25 Million GBP | -23.87% |
| 2019 | 12.15 Million GBP | -6.2% |
| 2018 | 12.95 Million GBP | 11.89% |
| 2017 | 11.57 Million GBP | -11.28% |
| 2016 | 13.05 Million GBP | -15.96% |
| 2015 | 15.52 Million GBP | 88.03% |
| 2014 | 8.25 Million GBP | -23.94% |
| 2013 | 10.85 Million GBP | 54.11% |
| 2012 | 7.04 Million GBP | 50.17% |
| 2011 | 4.69 Million GBP | -68.6% |
| 2010 | 14.94 Million GBP | 7039.55% |
| 2009 | 209.28 Thousand GBP | -96.7% |
| 2008 | 6.34 Million GBP | 1213.02% |
| 2007 | 483.2 Thousand GBP | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 6.4 Million GBP | 0.0% |
| 2023 Q4 | 5.9 Million GBP | 0.0% |
| 2023 Q2 | 5.8 Million GBP | 0.0% |
| 2023 FY | 11.61 Million GBP | 8.0% |
| 2022 FY | 10.75 Million USD | 24.81% |
| 2022 Q4 | 5.58 Million GBP | 0.0% |
| 2022 Q2 | 5.17 Million GBP | 0.0% |
| 2021 Q2 | 4.02 Million GBP | 0.0% |
| 2021 FY | 8.61 Million USD | -6.88% |
| 2020 FY | 9.25 Million GBP | -23.87% |
| 2020 Q4 | 4.36 Million GBP | 0.0% |
| 2020 Q2 | 4.93 Million GBP | 0.0% |
| 2019 Q2 | 6.46 Million GBP | 0.0% |
| 2019 Q4 | 5.68 Million GBP | 0.0% |
| 2019 FY | 12.15 Million GBP | -6.2% |
| 2018 Q4 | 6.2 Million GBP | 0.0% |
| 2018 FY | 12.95 Million GBP | 11.89% |
| 2017 FY | 11.57 Million GBP | -11.28% |
| 2016 FY | 13.05 Million GBP | -15.96% |
| 2015 FY | 15.52 Million GBP | 88.03% |
| 2014 FY | 8.25 Million GBP | -23.94% |
| 2013 FY | 10.85 Million GBP | 54.11% |
| 2012 Q3 | 426.25 Thousand GBP | 0.0% |
| 2012 Q2 | 426.25 Thousand GBP | 0.0% |
| 2012 Q1 | 426.25 Thousand GBP | 0.0% |
| 2012 FY | 7.04 Million GBP | 50.17% |
| 2012 Q4 | -1 Million GBP | -335.84% |
| 2011 Q1 | 287 Thousand GBP | 0.0% |
| 2011 FY | 4.69 Million GBP | -68.6% |
| 2011 Q4 | 426.25 Thousand GBP | 48.52% |
| 2011 Q3 | 287 Thousand GBP | 0.0% |
| 2011 Q2 | 287 Thousand GBP | 0.0% |
| 2010 FY | 14.94 Million GBP | 7039.55% |
| 2010 Q2 | 32.75 Thousand GBP | 0.0% |
| 2010 Q4 | 287 Thousand GBP | 776.34% |
| 2010 Q3 | 32.75 Thousand GBP | 0.0% |
| 2010 Q1 | 32.75 Thousand GBP | 0.0% |
| 2009 Q1 | 40.5 Thousand GBP | 0.0% |
| 2009 Q4 | 32.75 Thousand GBP | -19.14% |
| 2009 Q2 | 40.5 Thousand GBP | 0.0% |
| 2009 FY | 209.28 Thousand GBP | -96.7% |
| 2009 Q3 | 40.5 Thousand GBP | 0.0% |
| 2008 FY | 6.34 Million GBP | 1213.02% |
| 2008 Q4 | 40.5 Thousand GBP | -31.06% |
| 2008 Q2 | 58.75 Thousand GBP | 0.0% |
| 2008 Q1 | 58.75 Thousand GBP | 0.0% |
| 2008 Q3 | 58.75 Thousand GBP | 0.0% |
| 2007 Q1 | - GBP | 0.0% |
| 2007 Q2 | - GBP | 0.0% |
| 2007 Q3 | - GBP | 0.0% |
| 2007 Q4 | 58.75 Thousand GBP | 0.0% |
| 2007 FY | 483.2 Thousand GBP | 0.0% |
| 2006 Q4 | - GBP | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|